Company Valuation: Neolife

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023
Market Cap 1 6.866 23.36 16.13 3.687 6.929
Change - 240.27% -30.95% -77.14% 87.91%
Enterprise Value (EV) 1 7.143 23.31 17 4.341 7.35
Change - 226.3% -27.07% -74.46% 69.33%
P/E -8.1x -45.2x -95.3x -1.87x -13.2x
PBR 3.27x 10.9x 7.24x 1.41x 1.61x
PEG - 0.9x 1.4x -0x 0.2x
Capitalization / Revenue 0.79x 2.88x 1.46x 0.27x 0.52x
EV / Revenue 0.83x 2.87x 1.53x 0.32x 0.55x
EV / EBITDA -15.6x 68.8x 118x -4.85x 49.3x
EV / EBIT -11.3x -68.3x 1,953x -4.21x -13.9x
EV / FCF -18.3x 55.1x -15.6x -7.71x -
FCF Yield -5.47% 1.82% -6.41% -13% -
Dividend per Share 2 - - - - -
Rate of return - - - - -
EPS 2 -0.02 -0.01 -0.003233 -0.0376 -0.005432
Distribution rate - - - - -
Net sales 1 8.655 8.126 11.09 13.55 13.43
EBITDA 1 -0.4572 0.3389 0.1444 -0.8945 0.1491
EBIT 1 -0.6331 -0.3414 0.008702 -1.03 -0.5289
Net income 1 -0.9307 -0.5163 -0.1693 -3.625 -0.5235
Net Debt 1 0.2768 -0.0553 0.8645 0.6534 0.4211
Reference price 2 0.1620 0.4520 0.3080 0.0704 0.0719
Nbr of stocks (in thousands) 42,382 51,687 52,378 52,378 96,371
Announcement Date 25/06/20 05/04/22 05/04/22 28/04/23 29/04/24
1EUR in Million2EUR
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 5.42M
18.78x2.08x10.39x1.65% 61.97B
20.61x2.76x10.9x2.52% 49.2B
37.24x3.66x19.48x1.04% 37.75B
40.72x6.25x19.54x0.66% 36.53B
32.21x4.95x16.57x0.73% 35.76B
13.81x1.64x7.62x2.2% 34.29B
18.17x2.08x8.56x1.16% 21.9B
69.99x4.31x69.23x0.33% 21.82B
17.55x4.73x9.3x4.27% 18.3B
Average 29.90x 3.61x 19.07x 1.62% 32B
Weighted average by Cap. 28.16x 3.43x 16.86x 1.58%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Neolife

Historical PBR trend

Valuation ratios - PBR - Neolife

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Neolife

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Neolife